Home » Fact Sheets

Fact Sheets

 

Infections

Cytomegalovirus disease (CMV)
Mycobacterium avium complex (MAC)
Pneumocystis pneumonia (PCP)
Progressive multifocal leukoencephalopathy (PML)
Toxoplasmosis
Tuberculosis
Yeast infections—vaginal

Sexually Transmitted Infections

Chlamydia
Genital herpes
Gonorrhea
Hepatitis A
Hepatitis B
HPV, cervical dysplasia and cervical cancer
HPV, anal dysplasia and anal cancer
Syphilis

Sexually Transmitted Infections (Key Messages for Clients)

What you need to know about chlamydia
What you need to know about genital herpes
What you need to know about gonorrhea
What you need to know about hepatitis A
What you need to know about hepatitis B
What you need to know about human papillomavirus (HPV)
What you need to know about syphilis

Cancers

HPV, anal dysplasia and anal cancer
HPV, cervical dysplasia and cancer
Kaposi’s sarcoma (KS)
Lymphoma

Hepatitis

Daclatasvir (Daklinza)
Epclusa (velpatasvir + sofosbuvir)
Harvoni (ledipasvir + sofosbuvir)
Holkira Pak (dasabuvir + ombitasvir/paritaprevir/ritonavir)
Maviret (glecaprevir + pibrentasvir)
Ribavirin
Sofosbuvir (Sovaldi)
Technivie (ombitasvir/paritaprevir/ritonavir)
Vosevi (sofosbuvir + velpatasvir + voxilaprevir)
Zepatier (elbasvir + grazoprevir)
The epidemiology of hepatitis C in Canada
Hepatitis A
Hepatitis B

For more information, see Hepatitis C

Other Health Conditions

HIV and cardiovascular disease

For more information, see A Practical Guide to a Healthy Body for People Living with HIV and A Practical Guide to HIV Drug Side Effects

Prevention

Condoms for the prevention of HIV transmission
Oral pre-exposure prophylaxis (PrEP)
Post-exposure prophylaxis (PEP)
HIV treatment and an undetectable viral load to prevent HIV transmission
Immunizations (vaccinations) for people with HIV

Women and HIV

HPV, cervical dysplasia and cancer
The epidemiology of HIV in women
Yeast infections—vaginal

For more information, see A Practical Guide to a Healthy Body for People Living with HIV and A Practical Guide to HIV Drug Side Effects

HIV Drug Treatment

Co-formulations

Atripla
Combivir
Complera
Descovy
Genvoya
Kivexa
Odefsey
Prezcobix
Stribild
Triumeq
Trizivir
Truvada
 

Entry inhibitors

Maraviroc (Celsentri)
 

Fusion inhibitors

T-20 (enfuvirtide, Fuzeon)
 

Integrase inhibitors

Dolutegravir (Tivicay)
Raltegravir (Isentress)
 

Non-nukes

Delavirdine (Rescriptor)
Efavirenz (Sustiva)
Etravirine (Intelence)
Nevirapine (Viramune)
Rilpivirine (Edurant)
 

Nukes

3TC (lamivudine, Epivir)
Abacavir (Ziagen)
AZT (zidovudine, Retrovir)
d4T (stavudine, Zerit)
ddI (didanosine, Videx EC)
Tenofovir (Viread)
 

Protease inhibitors

Atazanavir (Reyataz)
Darunavir (Prezista)
Fosamprenavir (Telzir)
Indinavir (Crixivan)
Kaletra (Lopinavir/ritonavir)
Nelfinavir (Viracept)
Ritonavir (Norvir)
Saquinavir (Invirase)
Tipranavir (Aptivus)

Testing

Abacavir hypersensitivity screening
The HIV testing process
HIV testing technologies
HIV viral load testing
Tropism testing

Supplements

Acetyl-L-carnitine and L-carnitine
NAC (N-acetyl-cysteine)

For more information, see A Practical Guide to Herbal Therapies for People Living With HIV and A Practical Guide to Nutrition for People Living with HIV

HIV and Hepatitis C in Canada

The epidemiology of hepatitis C in Canada
The epidemiology of HIV in Canada
The epidemiology of HIV in females
The epidemiology of HIV in gay, bisexual and other men who have sex with men
The epidemiology of HIV in people who inject drugs in Canada
The epidemiology of HIV in youth

Street/Recreational Drugs

Recreational drugs and HIV